| scholarly article | Q13442814 |
| P50 | author | Nathan A Lemp | Q89240597 |
| P2093 | author name string | Noriyuki Kasahara | |
| Michael Koss | |||
| Tariq Shah | |||
| James C Cicciarelli | |||
| David I Min | |||
| Katrin Hacke | |||
| Robert Naraghi | |||
| Kevin M Burns | |||
| Youngil Chang | |||
| P2860 | cites work | The chemical structure of the C4d fragment of the human complement component C4. | Q34187799 |
| International standardization of criteria for the histologic diagnosis of renal allograft rejection: the Banff working classification of kidney transplant pathology | Q34354852 | ||
| Role of complement in graft rejection after organ transplantation | Q34697846 | ||
| Complement in organ transplantation. | Q35001174 | ||
| Humoral theory of transplantation | Q35142603 | ||
| De Novo Donor-Specific HLA Antibody Development and Peripheral CD4(+)CD25(high) Cells in Kidney Transplant Recipients: A Place for Interaction? | Q36204503 | ||
| IgG Donor-Specific Anti-Human HLA Antibody Subclasses and Kidney Allograft Antibody-Mediated Injury | Q36417907 | ||
| Subclass analysis of donor HLA-specific IgG in antibody-incompatible renal transplantation reveals a significant association of IgG4 with rejection and graft failure. | Q37155993 | ||
| Diagnostic Contribution of Donor-Specific Antibody Characteristics to Uncover Late Silent Antibody-Mediated Rejection-Results of a Cross-Sectional Screening Study. | Q40779288 | ||
| The role of anti-HLA antibodies in heart transplantation | Q41180459 | ||
| Donor-specific HLA antibodies: evaluating the risk for graft loss in renal transplant recipients with isotype switch from complement fixing IgG1/IgG3 to noncomplement fixing IgG2/IgG4 anti-HLA alloantibodies | Q45106203 | ||
| Posttransplant de novo donor-specific hla antibodies identify pediatric kidney recipients at risk for late antibody-mediated rejection. | Q45972310 | ||
| Complement-binding anti-HLA antibodies and kidney-allograft survival | Q46141053 | ||
| Donor-specific human leukocyte antigen antibodies of the immunoglobulin G3 subclass are associated with chronic rejection and graft loss after liver transplantation. | Q46174297 | ||
| De novo donor specific antibodies and patient outcomes in renal transplantation | Q46293237 | ||
| Pathological study on the relationship between C4d, CD59 and C5b-9 in acute renal allograft rejection | Q47361577 | ||
| Significance of the positive crossmatch test in kidney transplantation | Q47800073 | ||
| Evolution and clinical pathologic correlations of de novo donor-specific HLA antibody post kidney transplant. | Q48005087 | ||
| Frequency and clinical implications of development of donor-specific and non-donor-specific HLA antibodies after kidney transplantation. | Q50765005 | ||
| C1q Binding Activity of De Novo Donor-specific HLA Antibodies in Renal Transplant Recipients With and Without Antibody-mediated Rejection. | Q53225887 | ||
| Acute humoral rejection in kidney transplantation: II. Morphology, immunopathology, and pathologic classification. | Q54380136 | ||
| Mechanisms of allergen-specific immunotherapy | Q59271653 | ||
| Pretransplant Donor-Specific HLA Class-I and -II Antibodies Are Associated With an Increased Risk for Kidney Graft Failure | Q60182181 | ||
| Vascular deposition of complement-split products in kidney allografts with cell-mediated rejection | Q67773387 | ||
| The significance of the anti-class I response. II. Clinical and pathologic features of renal transplants with anti-class I-like antibody | Q68076654 | ||
| Hyperacute and acute kidney graft rejection due to antibodies against B cells | Q68209607 | ||
| Posttransplant antidonor antibodies and graft rejection. Evaluation by two-color flow cytometry | Q69486597 | ||
| The humoral immune response towards HLA class II determinants in renal transplantation | Q71769742 | ||
| Capillary deposition of C4d complement fragment and early renal graft loss | Q72791721 | ||
| Pretransplant IgG subclasses of donor-specific human leukocyte antigen antibodies and development of antibody-mediated rejection | Q84261290 | ||
| De novo DQ donor-specific antibodies are associated with a significant risk of antibody-mediated rejection and transplant glomerulopathy | Q84464302 | ||
| Clinical significance of post kidney transplant de novo DSA in otherwise stable grafts | Q84512213 | ||
| Significant IgG subclass heterogeneity in HLA-specific antibodies: Implications for pathogenicity, prognosis, and the rejection response | Q86030889 | ||
| Impact of IgG3 subclass and C1q-fixing donor-specific HLA alloantibodies on rejection and survival in liver transplantation | Q86932430 | ||
| Immunoglobulin G subclass analysis of HLA donor specific antibodies in heart and renal transplant recipients | Q95471559 | ||
| P275 | copyright license | Creative Commons Attribution 4.0 International | Q20007257 |
| P6216 | copyright status | copyrighted | Q50423863 |
| P921 | main subject | biopsy | Q179991 |
| P304 | page(s) | 1652931 | |
| P577 | publication date | 2017-01-15 | |
| P1433 | published in | Journal of Immunology Research | Q26841936 |
| P1476 | title | Renal Transplant Patients Biopsied for Cause and Tested for C4d, DSA, and IgG Subclasses and C1q: Which Humoral Markers Improve Diagnosis and Outcomes? | |
| P478 | volume | 2017 |
| Q39445381 | Application, technical issues, and interpretation of C1q for graft outcome |
| Q58566650 | Do natural antibodies have a detrimental effect after kidney transplantation? |
| Q39217968 | Not All Antibodies Are Created Equal: Factors That Influence Antibody Mediated Rejection |
| Q47109132 | Protective Effects of Ophiocordyceps lanpingensis on Glycerol-Induced Acute Renal Failure in Mice. |
Search more.